These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 3612128

  • 1. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?
    Rosengren B, Månsson JE, Svennerholm L.
    J Neurochem; 1987 Sep; 49(3):834-40. PubMed ID: 3612128
    [Abstract] [Full Text] [Related]

  • 2. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
    Kodama T, Togawa T, Tsukimura T, Kawashima I, Matsuoka K, Kitakaze K, Tsuji D, Itoh K, Ishida Y, Suzuki M, Suzuki T, Sakuraba H.
    PLoS One; 2011 Sep; 6(12):e29074. PubMed ID: 22205997
    [Abstract] [Full Text] [Related]

  • 3. Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain.
    Neuenhofer S, Conzelmann E, Schwarzmann G, Egge H, Sandhoff K.
    Biol Chem Hoppe Seyler; 1986 Mar; 367(3):241-4. PubMed ID: 3707714
    [Abstract] [Full Text] [Related]

  • 4. Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses.
    Kobayashi T, Goto I, Okada S, Orii T, Ohno K, Nakano T.
    J Neurochem; 1992 Oct; 59(4):1452-8. PubMed ID: 1402895
    [Abstract] [Full Text] [Related]

  • 5. Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease.
    Chen Y, Allegood J, Liu Y, Wang E, Cachón-Gonzalez B, Cox TM, Merrill AH, Sullards MC.
    Anal Chem; 2008 Apr 15; 80(8):2780-8. PubMed ID: 18314967
    [Abstract] [Full Text] [Related]

  • 6. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.
    Raghavan S, Krusell A, Lyerla TA, Bremer EG, Kolodny EH.
    Biochim Biophys Acta; 1985 Apr 25; 834(2):238-48. PubMed ID: 3995063
    [Abstract] [Full Text] [Related]

  • 7. Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assay.
    Bierfreund U, Lemm T, Hoffmann A, Uhlhorn-Dierks G, Childs RA, Yuen CT, Feizi T, Sandhoff K.
    Neurochem Res; 1999 Feb 25; 24(2):295-300. PubMed ID: 9972878
    [Abstract] [Full Text] [Related]

  • 8. In cellulo examination of a beta-alpha hybrid construct of beta-hexosaminidase A subunits, reported to interact with the GM2 activator protein and hydrolyze GM2 ganglioside.
    Sinici I, Yonekawa S, Tkachyova I, Gray SJ, Samulski RJ, Wakarchuk W, Mark BL, Mahuran DJ.
    PLoS One; 2013 Feb 25; 8(3):e57908. PubMed ID: 23483939
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.
    Taniike M, Inui K, Hirabayashi Y, Tsukamoto H, Nishimoto J, Midorikawa M, Okada S, Yabuuchi H.
    J Inherit Metab Dis; 1989 Feb 25; 12 Suppl 2():372-4. PubMed ID: 2512447
    [No Abstract] [Full Text] [Related]

  • 10. Ganglioside-composition of brain in Tay-Sachs disease: increased amounts of GD2 and N-acetyl-beta-D-galactosaminyl GD1a ganglioside.
    Iwamori M, Nagai Y.
    J Neurochem; 1979 Mar 25; 32(3):767-77. PubMed ID: 430057
    [No Abstract] [Full Text] [Related]

  • 11. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J, Binns HJ.
    Clin Chim Acta; 1986 Apr 15; 156(1):41-9. PubMed ID: 2938852
    [Abstract] [Full Text] [Related]

  • 12. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ, Trasler JM, Igdoura S, Michaud J, Hanal N, Gravel RA.
    Hum Mol Genet; 1997 Oct 15; 6(11):1879-85. PubMed ID: 9302266
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides.
    Trasler J, Saberi F, Somani IH, Adamali HI, Huang JQ, Fortunato SR, Ritter G, Gu M, Aebersold R, Gravel RA, Hermo L.
    Endocrinology; 1998 Jul 15; 139(7):3280-8. PubMed ID: 9645704
    [Abstract] [Full Text] [Related]

  • 14. Characterization of some minor gangliosides in Tay-Sachs brains.
    Yu RK, Itoh T, Yohe HC, Macala LJ.
    Brain Res; 1983 Sep 19; 275(1):47-52. PubMed ID: 6414648
    [No Abstract] [Full Text] [Related]

  • 15. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
    Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, Westphal H, McDonald MP, Crawley JN, Sandhoff K, Suzuki K, Proia RL.
    Nat Genet; 1995 Oct 19; 11(2):170-6. PubMed ID: 7550345
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometry.
    Gu J, Tifft CJ, Soldin SJ.
    Clin Biochem; 2008 Apr 19; 41(6):413-7. PubMed ID: 18241673
    [Abstract] [Full Text] [Related]

  • 17. [Identification of GM2-gangliosidosis using an in vitro loading test].
    Akhunov VS, Krasnopol'skaia KD.
    Vopr Med Khim; 1987 Apr 19; 33(4):115-9. PubMed ID: 3116767
    [Abstract] [Full Text] [Related]

  • 18. Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling.
    Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL.
    Hum Mol Genet; 2002 May 15; 11(11):1343-50. PubMed ID: 12019216
    [Abstract] [Full Text] [Related]

  • 19. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.
    Phaneuf D, Wakamatsu N, Huang JQ, Borowski A, Peterson AC, Fortunato SR, Ritter G, Igdoura SA, Morales CR, Benoit G, Akerman BR, Leclerc D, Hanai N, Marth JD, Trasler JM, Gravel RA.
    Hum Mol Genet; 1996 Jan 15; 5(1):1-14. PubMed ID: 8789434
    [Abstract] [Full Text] [Related]

  • 20. Plasma GM2 ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-Gangliosidosis.
    Blondel A, Kraoua I, Marcelino C, Khrouf W, Schlemmer D, Ganne B, Caillaud C, Fernández-Eulate G, Turki IBY, Dauriat B, Bonnefont-Rousselot D, Nadjar Y, Lamari F.
    Mol Genet Metab; 2023 Feb 15; 138(2):106983. PubMed ID: 36709536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.